Fibrinolytic System and Cancer: Diagnostic and Therapeutic Applications

Fibrinolytic System and Cancer: Diagnostic and Therapeutic Applications

Fibrinolysis is a crucial physiological process that helps to maintain a hemostatic balance by counteracting excessive thrombosis. The components of the fibrinolytic system are well established and are associated with a wide array of physiological and pathophysiological processes. The aberrant expre...

Full description

Bibliographic Details
Main Authors:	Niaz Mahmood, Shafaat A. Rabbani
Format:	Article
Language:	English
Published:	MDPI AG 2021-04-01
Series:	International Journal of Molecular Sciences
Subjects:	uPA uPAR PAI-1 PA system cancer
Online Access:	https://www.mdpi.com/1422-0067/22/9/4358

Similar Items

The uPA/uPAR System Orchestrates the Inflammatory Response, Vascular Homeostasis, and Immune System in Fibrosis Progression
by: Yosuke Kanno
Published: (2023-01-01)

Growth Inhibition of MDA-MB-231 Cell Line by Peptides Designed based on uPA
by: Parastoo Tarighi, et al.
Published: (2015-10-01)

Posttranscriptional Regulation of the Plasminogen Activation System by Non-Coding RNA in Cancer
by: Mariaevelina Alfieri, et al.
Published: (2023-01-01)

Specific knockdown of uPA/uPAR attenuates invasion in glioblastoma cells and xenografts by inhibition of cleavage and trafficking of Notch -1 receptor
by: Gujrati Meena, et al.
Published: (2011-10-01)

Enterococcus faecalis promotes a migratory and invasive phenotype in colon cancer cells
by: Ashley J. Williamson, et al.
Published: (2022-05-01)

Targeting uPA-uPAR interaction to improve intestinal epithelial barrier integrity in inflammatory bowel disease
by: Yang Cheng, et al.
Published: (2022-01-01)

Role of flow cytometry in multiple myeloma and the prognostic significance of CD87 (uPAR) expression
by: Murat Albayrak, et al.
Published: (2010-09-01)

The Association of uPA, uPAR, and suPAR System with Inflammation and Joint Damage in Rheumatoid Arthritis: suPAR as a Biomarker in the Light of a Personalized Medicine Perspective
by: Maurizio Benucci, et al.
Published: (2022-12-01)

Urokinase-Type Plasminogen Activator Receptor Regulates Prosurvival and Angiogenic Properties of Cardiac Mesenchymal Stromal Cells
by: Konstantin Dergilev, et al.
Published: (2023-10-01)

Exogenous Urokinase Inhibits Proteasomal Degradation of Its Cognate Urokinase Plasminogen Activator Receptor
by: Ran Zhu, et al.
Published: (2022-08-01)

The Role of the Plasminogen Activation System in Angioedema: Novel Insights on the Pathogenesis
by: Filomena Napolitano, et al.
Published: (2021-02-01)

Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications
by: Niaz Mahmood, et al.
Published: (2018-02-01)

Urokinase System in Pathogenesis of Pulmonary Fibrosis: A Hidden Threat of COVID-19
by: Anna A. Shmakova, et al.
Published: (2023-01-01)

The Urokinase Plasminogen Activation System in Pancreatic Cancer: Prospective Diagnostic and Therapeutic Targets
by: Ashna A. Kumar, et al.
Published: (2022-01-01)

Assessment of Ki67 and uPA/PAI-1 expression in intermediate-risk early stage breast cancers
by: Elise Deluche, et al.
Published: (2017-09-01)

Adjuvant Docetaxel in Node-Negative Breast Cancer Patients: A Randomized Trial of AGO-Breast Study Group, German Breast Group, and EORTC-Pathobiology Group
by: Christoph Thomssen, et al.
Published: (2023-03-01)

Downregulation of SPINK13 Promotes Metastasis by Regulating uPA in Ovarian Cancer Cells
by: Shengyun Cai, et al.
Published: (2018-02-01)

Experimental and Clinical Evidence Supports the Use of Urokinase Plasminogen Activation System Components as Clinically Relevant Biomarkers in Gastroesophageal Adenocarcinoma
by: Gary Tincknell, et al.
Published: (2021-08-01)

Overexpression of SERBP1 (Plasminogen activator inhibitor 1 RNA binding protein) in human breast cancer is correlated with favourable prognosis
by: Serce Nuran Bektas, et al.
Published: (2012-12-01)

SPINKs in Tumors: Potential Therapeutic Targets
by: Chengcheng Liao, et al.
Published: (2022-02-01)

Coordinated expression of vascular endothelial growth factor A and urokinase-type plasminogen activator contributes to classical swine fever virus Shimen infection in macrophages
by: Xiaocheng Gong, et al.
Published: (2019-03-01)

Elevated levels of serum urokinase plasminogen activator predict poor prognosis in hepatocellular carcinoma after resection
by: Ming-Chao Tsai, et al.
Published: (2019-12-01)

Staphylococcus aureus on the effect of expression of MMPs/TIMPs and uPA system in bovine mammary fibroblasts
by: Zengqiang Miao, et al.
Published: (2021-06-01)

In Vitro Study of the Fibrinolytic Activity via Single Chain Urokinase-Type Plasminogen Activator and Molecular Docking of FGFC1
by: Chunli Gao, et al.
Published: (2021-03-01)

Distinguishing Plasmin-Generating Microvesicles: Tiny Messengers Involved in Fibrinolysis and Proteolysis
by: Laurent Plawinski, et al.
Published: (2023-01-01)

TEM8 functions as a receptor for uPA and mediates uPA-stimulated EGFR phosphorylation
by: Lian-Cheng Zhang, et al.
Published: (2018-09-01)

Inhibitors of Urokinase Type Plasminogen Activator and Cytostatic Activity from Crude Plants Extracts
by: Augusto Carvajal, et al.
Published: (2013-07-01)

The Urokinase Receptor: A Multifunctional Receptor in Cancer Cell Biology. Therapeutic Implications
by: Anna Li Santi, et al.
Published: (2021-04-01)

The uPA System Differentially Alters Fibroblast Fate and Profibrotic Ability in Skin Fibrosis
by: Ming-Li Zou, et al.
Published: (2022-03-01)

Upregulation of P2Y2R, Active uPA, and PAI-1 Are Essential Components of Hantavirus Cardiopulmonary Syndrome
by: Virginie Bondu, et al.
Published: (2018-05-01)

Editorial: Molecular regulation of tumor cells migration and metastatic growth
by: Michelle L. Matter, et al.
Published: (2023-11-01)

Shikonin mediated anti-acute lung injury and hemostatic effects via inhibiting uPA
by: Chengcheng Li, et al.
Published: (2023-06-01)

HGF/c-Met: A Key Promoter in Liver Regeneration
by: Yang Zhao, et al.
Published: (2022-03-01)

Cancer Progression Gene Expression Profiling Identifies the Urokinase Plasminogen Activator Receptor as a Biomarker of Metastasis in Cutaneous Squamous Cell Carcinoma
by: Elahe Minaei, et al.
Published: (2022-04-01)

TIPE2 acts as a biomarker for tumor aggressiveness and suppresses cell invasiveness in papillary thyroid cancer (PTC)
by: Wenyu Jia, et al.
Published: (2018-08-01)

Research Progress of Targeting uPA-uPAR System in Tumor Therapy
by: CAI Weiwen, et al.
Published: (2023-02-01)

Urokinase-type Plasminogen Activator and Plasminogen Activator Inhibitor Induction by Etoposide in a Glioblastoma Cell Strain
by: Branko Brdar, et al.
Published: (2002-01-01)

Thrombolysis Combined Therapy Using CuS@SiO2-PEG/uPA Nanoparticles
by: Dapeng Fu, et al.
Published: (2021-03-01)

Plasmin and Plasminogen System in the Tumor Microenvironment: Implications for Cancer Diagnosis, Prognosis, and Therapy
by: Alamelu G. Bharadwaj, et al.
Published: (2021-04-01)

Plasminogen Activators in Neurovascular and Neurodegenerative Disorders
by: Manuel Yepes, et al.
Published: (2021-04-01)